The Consolidated Appropriations Act, 2026, which provides consolidated appropriations for the fiscal year ending September 30, 2026, includes critical directives to the Centers for Medicare & Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), and the Health Resources and Services Administration (HRSA) to advance key Peripheral Artery Disease (PAD) programs.

The SCAI-led PAD Working Group—a coalition of cardiovascular societies and stakeholder organizations—is now focused on ensuring that future appropriations continue to prioritize PAD. In parallel, the coalition is working with federal agencies to expand education and early-detection initiatives aimed at reducing preventable amputations and improving patient outcomes.

The relevant statutory language can be found in the House and Senate versions of the Consolidated Appropriations Act of 2026 (H.R. 7148):

• House language: See page 88
• Senate language: See page 204

These provisions represent an important step forward in elevating PAD as a national public health priority and strengthening federal efforts to improve diagnosis, treatment, and long-term outcomes for patients.